Neurotech, Neuromodulation, Alzheimers.
onset Alzheimer’s patients, as if not to appear too positive about the technology that may seem too edgy. Not unlike Big Pharma, there are three major (market cap in the billions of dollars) neuromodulation players — Abbott, Boston Scientific and Medtronic — who have a substantial portfolio of